Vaginal misoprostol versus intravenous oxytocin for the management of second-trimester pregnancies with intrauterine fetal death: A randomized clinical trial

2015 ◽  
Vol 42 (3) ◽  
pp. 246-251 ◽  
Author(s):  
Zhila Abediasl ◽  
Mahdi Sheikh ◽  
Parichehr Pooransari ◽  
Zahra Farahani ◽  
Farah Kalani
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Fetal Death ◽  
Intrauterine Fetal Death ◽  
Second Trimester ◽  
Vaginal Misoprostol

Laminaria vs. vaginal misoprostol for cervical preparation before second-trimester surgical abortion: a randomized clinical trial

Contraception ◽  
2015 ◽  
Vol 91 (5) ◽  
pp. 406-411 ◽  
Author(s):  
Ron Sagiv ◽  
Yossi Mizrachi ◽  
Hagit Glickman ◽  
Ram Kerner ◽  
Ran Keidar ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Second Trimester ◽  
Cervical Preparation ◽  
Vaginal Misoprostol ◽  
Surgical Abortion

Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial

2012 ◽  
Vol 287 (1) ◽  
pp. 65-69 ◽  
Author(s):  
Fateme Davari Tanha ◽  
Tahmineh Golgachi ◽  
Nasrin Niroomand ◽  
Mahsa Ghajarzadeh ◽  
Reza Nasr
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Second Trimester ◽  
Vaginal Misoprostol

scholarly journals The combination route versus sublingual and vaginal misoprostol for the termination of 13 to 24 week pregnancies: A randomized clinical trial

2015 ◽  
Vol 54 (6) ◽  
pp. 660-665 ◽  
Author(s):  
Fatemeh Rahimi-Sharbaf ◽  
Khadijeh Adabi ◽  
Mehrnaz Valadan ◽  
Mahboobeh Shirazi ◽  
Sepideh Nekuie ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Vaginal Misoprostol

80: Increased risk of intrauterine fetal death in women with fibroids at routine second trimester ultrasound

2009 ◽  
Vol 201 (6) ◽  
pp. S45
Author(s):  
Molly Stout ◽  
Anthony Odibo ◽  
George Macones ◽  
Alison Cahill
Keyword(s):  
Fetal Death ◽  
Intrauterine Fetal Death ◽  
Second Trimester ◽  
Increased Risk

scholarly journals Low Dose Vaginal Misoprostol in the Management of Women with Intrauterine Fetal Death

2010 ◽  
Vol 3 ◽  
pp. CMWH.S5797
Author(s):  
M.N. El-Gharib ◽  
M.T. El-Ebyary ◽  
T.S. Alhawary ◽  
S.H. Elshourbagy
Keyword(s):  
Fetal Death ◽  
Mean Value ◽  
University Hospital ◽  
Intrauterine Fetal Death ◽  
Third Trimester ◽  
Trimester Pregnancy ◽  
Observational Cohort ◽  
The Mean ◽  
Vaginal Misoprostol ◽  
Duration Of Gestation

Objectives The study was conducted to assess the effectiveness and side effects of vaginal misoprostol (Vagiprost® tablet) in termination of second and third trimester pregnancy complicated with intrauterine fetal death. Design A prospective observational cohort study. Setting Tanta University Hospital. Patients The study was carried out on 324 women with fetal demise in the second and third trimesters. Cases were collected during the period from January 2008 to December 2009. Intervention All patients were subjected to history taking, physical examination, Bishop Scoring. Application of 25 μg misoprostol in the posterior fornix of the vagina, this will be repeated every 4 hours over 24 hours. The adverse effects, progress, and outcomes were assessed. Results the success rate was 90% and 45% in women with third and second trimesters respectively. The mean induction-termination interval was 8.95 ± 2.63 and 15.3 ± 5.37 hours for women with third and second trimesters respectively. The induction termination interval correlated negatively with the duration of gestation. Approximately, 90% of second trimester and 55% of third trimester women required oxytocin augmentation. The mean value of total required dose of misoprostol was 166.3 ± 7.5 and 120 ± 28.79 μg for women with second and third trimesters respectively. Conclusion Vagiprost appears to be a safe, effective, practical, and inexpensive method for termination of third trimester pregnancy complicated with of intrauterine fetal death (IUFD), its effects increase with parity and duration of gestation.

New technique for managing second trimester intrauterine fetal death

1989 ◽  
Vol 28 (3) ◽  
pp. 295-297
Author(s):  
A. Malpani ◽  
A. Malpani ◽  
U. Krishna
Keyword(s):  
Fetal Death ◽  
New Technique ◽  
Intrauterine Fetal Death ◽  
Second Trimester

Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial

Contraception ◽  
2007 ◽  
Vol 75 (3) ◽  
pp. 230-237 ◽  
Author(s):  
Josep Lluis Carbonell ◽  
Francisca García Gallego ◽  
Margardell Perez Llorente ◽  
Santiago Barambio Bermudez ◽  
Eugenia Sánchez Sala ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Second Trimester ◽  
Trimester Abortion ◽  
Cervical Priming ◽  
Sublingual Misoprostol ◽  
Second Trimester Abortion
Sign in / Sign up

Export Citation Format

Share Document